A prospective study on prevalence and determinants of ototoxicity during treatment of childhood cancer - The SOUND study

Prinses Máxima Centrum0 个研究点目标入组 600 人开始时间: 待定最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•In order to be eligible to participate in stratum 1, a subject must meet all of
•the following criteria:
•1. Diagnosed with a CNS tumor or solid tumor in the Princess Máxima Center and
•2. Planned to receive treatment with cisplatin and/or carboplatin and/ or
•oxaliplatin and/or CNS-/ENT irradiation and/or CNS-/ENT surgery and will
•receive audiological examination as part of standard of care;
•3. Children aged 0 until 19 years at time of diagnosis;
•4. Biobank/ over de drempel PIF, Informed Consent Form (ICF) signed for
•collection of standard of care data.
•In order to be eligible to participate in stratum 2, a subject must meet all of
•the following criteria:
•1. Diagnosed with a CNS tumor or solid tumor in the Princess Máxima Center and
•2. Not planned to receive treatment with cisplatin and/or carboplatin and/or
•oxaliplatin, or planned to receive CNS-/ENT irradiation and/or CNS-/ENT surgery
•without audiological examination as part of standard of care;
•3. Children aged 0 until 19 at time of diagnosis;
•4. Study specific informed consent form (ICF) signed prior to participation in

发起方

Prinses Máxima Centrum